Scott has spent the most recent part of his career developing successful medical cannabis companies in both Canada and United States. This includes Canadian federal and US state licensed cannabis production, product development, funded research and licensed wholesale cannabis distribution. Currently, he is the CEO of Molecular Science Corp., a Canadian laboratory services company that will deliver analytical testing & data-driven business intelligence to the growing cannabis economy. Formerly, Scott was CEO and business development lead at THC BioMed (THC.v), Canabo (CMM.v) and Empower Clinics (USA) and is currently a Director of Supreme Pharmaceuticals ($SL.c). Scott also continues advising banking and law firms in the sector.